P. Lundin
AstraZeneca (Brazil)(BR)AstraZeneca (Italy)(IT)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Helicobacter pylori-related gastroenterology studies, Gastroesophageal reflux and treatments, Microscopic Colitis, Neuroendocrine regulation and behavior
Most-Cited Works
- → Intestinal Permeability Is Associated With Visceral Adiposity in Healthy Women(2011)162 cited
- → A pharmacoscintigraphic evaluation of oral budesonide given as controlled‐release (Entocort) capsules(2003)109 cited
- → Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn's disease(2002)51 cited
- → Effect of food on the pharmacokinetics of budesonide controlled ileal release capsules in patients with active Crohn’s disease(2001)34 cited
- → Enhancing Effects of Monohexanoin and Two Other Medium-Chain Glyceride Vehicles on Intestinal Absorption of Desmopressin (dDAVP)(1997)30 cited
- Pulmonary delivery of intratracheally instilled and aerosolized cyclosporine A to young and adult rats.(1997)
- → Bioimpedance spectroscopy: a new tool to assess early esophageal changes linked to gastroesophageal reflux disease?(2011)10 cited
- → Bidirectional Small Intestinal Permeability Changes to Different-Sized Molecules After HCl-Induced Injury in the Rat(1997)9 cited
- → Intestinal Inflammation and Barrier Function in HLA-B27/β2-Microglobulin Transgenic Rats(1997)9 cited
- → Enhanced intestinal absorption of oxytocin peptide analogues in the absence of pancreatic juice in pigs.(1995)9 cited